Table 2

Primary and secondary outcomes results

 Mean (SE)Mean difference* (95% CI)p Value*
HSS (n=42)HHHFNC (n=32)
Primary outcome
 RACS01.24 (0.5)0.91 (0.56)0.33 (−1.17 to 1.84)0.6
 RACS10.95 (0.48)0.38 (0.55)0.57 (−0.89 to 2.03)0.4
 RACS20.36 (0.39)0.39 (0.46)0.07 (−1.12 to1.26)0.9
 RACS30.19 (0.49)−0.61 (0.60)0.79 (−0.75 to 2.33)0.3
 RACS4−0.18 (0.54)1.04 (0.70)−1.22 (−2.99 to 0.55)0.2
 RACS50.22 (0.48)0.8 (0.64)−0.58 (−2.187 to1.02)0.5
First secondary outcome
 Comfort110.91 (0.34)10.81 (0.38)0.09 (−0.93 to 1.11)0.9
 Comfort211.60 (0.29)11.35 (0.34)0.25 (−0.65 to 1.12)0.6
 Comfort312.12 (0.34)11.62 (0.41)0.52 (−0.54 to 1.57)0.3
 Comfort412.45 (0.38)11.87 (0.46)0.58 (−0.61 to 1.77)0.3
 Comfort512.21 (0.41)12.04 (0.49)0.17 (−1.09 to 1.44)0.8
 Comfort612.77 (0.38)12.95 (0.46)−0.18 (−1.38 to 1.02)0.8
Other secondary outcomes
 LOS days median(IQR)4.5 (3)5 (4)0.8
 PICU n (%)5 (11.9%)5 (15.6%)0.5
  • *Mean difference estimated by mixed models. p Value result of post hoc pairwise comparisons for treatment.

  • HHHFNC, heated humidified high-flow nasal cannula; HSS, hypertonic saline solution; HSS, hypertonic saline solution; LOS, length of hospital stay; PICU, Pediatric Intensive Care Unit; RACS, Respiratory Assessment Change Score, change in RDAI + change in % RR; RDAI, Respiratory Distress Assessment Instrument; RR, respiratory rate.